공시 • Mar 31
PSYC Corporation announced that it has received $0.35 million in funding PSYC Corporation announced that it has issued a total of 17,500,000 common shares at an issue price of $0.02 per share for gross proceeds of $350,000 on March 29, 2022. The company also issued warrant options for the right to purchase up to an additional 20,000,000 shares over the next 12 months. The transaction included participation from individual investor, Trent Sullivan. 공시 • Jan 21
Global Trac Solutions, Inc. Executes Joint Venture Partnership Agreement with PsycheDev Inc Global Trac Solutions Inc. announced that the Company has executed a Joint Venture Partnership Agreement with PsycheDev Inc. The formation of the JV creates a unique opportunity for PSYC to begin its entry into the sector of digital mental health which recently, in management’s estimation, has demonstrated significant growth potential amid the ongoing COVID-19 pandemic. It also setups the potential, although there can be no guarantees, for the Company to establish a revenue stream through the intended monetization of the application following its launch later in 2021. Through the JV, PSYC will work in collaboration with PsycheDev on the co-development and launch of its digital mental health application and platform designed to provide users with the ability to leverage the power and benefits of self-guided trips and mental exercises with the intent of achieving a more profound state of mental health and well-being. Furthermore, as part of the JV, PSYC receives an initial 15% equity stake in PsycheDev in conjunction with its investment into PsycheDev. The companies intend to dedicate the next several months towards the continued to development of the PsycheDev application and will also work on establishing an effective go-to-market strategy for the app and as they aim for an official launch towards the end of the second half of this year. 공시 • Jan 06
Global Trac Solutions, Inc Announces Formation of Advisory Board Global Trac Solutions Inc. announced the formation of the company Advisory Board. Joining its newly established board is George Y. Salameh, MD, Hyder A. Khoja, PhD, and Kelli Foulkroud, MS, LPA, LPC, RYT. And as PSYC moves ahead with its growth within the emerging sectors of medicinal psychedelics and digital mental health, these advisors bring tremendous value to the Company through their collective knowledge and expertise. 공시 • Dec 26
Global Trac Solutions Inc. Launches A New Web Platform for Psychedelic Spotlight Web Magazine Global Trac Solutions Inc. announced that the company has launched a new web platform for its Psychedelic Spotlight web magazine. The new site is part of the continued growth Psychedelic Spotlight is experiencing. In fourth quarter of 2020 a record number of new users visited the site, breaking page view records. The company, through its digital media marketing partner, SunCity Advising, expects to rollout additional pages and features for the Psychedelic Spotlight website over the next several weeks in its ongoing mission of delivering the most resourceful and content-rich web platform in the sector of medicinal psychedelics. 공시 • Oct 27
Global Trac Solutions Inc. Appoints Jill Ettinger as the Platform’s New Content Director and Managing Editor Global Trac Solutions Inc. announced that in the company’s ongoing efforts to optimize content production for its digital media platform within the expanding sector of medicinal psychedelics, it is welcoming Jill Ettinger as the platform’s new Content Director and Managing Editor. Ms. Ettinger brings with her more than a decade of content leadership experience. She most recently served as the Head of Content for vegan lifestyle publication LIVEKINDLY, leading it to more than 100 million monthly cross-platform impressions. 공시 • Oct 05
Global Trac Solutions, Inc. Establishes an Affiliate Partnership with BodyChek Wellness Global Trac Solutions Inc. announced that in an effort to diversify its expanding digital media platform for Psychedelic Spotlight, and further leverage its position within the burgeoning industry of psychedelic medicine and mental wellbeing, the Company has established an affiliate partnership with BodyChek Wellness (“BodyChek”). The Company contends that its initial focus within this affiliate partnership will be limited to only promoting and endorsing the sale of BodyChek’s line of functional mushroom products, and more specifically its “Enhance Mushroom +” for Focus and Clarity, and its “Enhance Mushroom +” for Energy and Endurance.